Treatment of Copper Intra Uterine Device Associated Heavy Menstrual Blood Loss

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

Intrauterine contraceptive device is the most commonly reversible method used among women of reproductive age worldwide. Almost one in five married contraceptive users is currently using Intrauterine contraceptive device. The Egyptian demographic and health survey results indicate that 30% of currently married women interviewed in the Egyptian demographic and health survey were using Intrauterine contraceptive device. Main reasons for discontinuation of Intrauterine contraceptive device as cited by women were excessive bleeding per vagina 39.68%, abdominal pain 38.62%, low backache35.97%.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Calcium; Calcium Dobesilate; Calcium, Dietary; Copper; Tranexamic Acid

Criteria

Inclusion Criteria:

1. Women usingsopperT380A and reporting heavy menstrual blood loss during use.

2. Menorrhagia , will be defined as a Pictorial blood loss assessment chart-Score greater than 100.

3. No contraindication to drugs used in treatment.

4. No other cause for heavy menstrual blood loss

Exclusion Criteria:

1. Refusing to participate.

2. Irregular menstrual cycle.

3. Misplaced Intrauterine device.